What is the appropriate medication regimen for managing an acute gout flare in an elderly patient, including considerations for renal function, diabetes, and drug interactions?

Managing Acute Gout Flares in Elderly Patients

For elderly patients with acute gout, oral corticosteroids (prednisone/prednisolone) are the preferred first-line treatment, followed by low-dose colchicine as an alternative, while NSAIDs should be avoided due to high rates of renal impairment, cardiovascular disease, and gastrointestinal complications in this population. 1, 2

Acute Flare Management Algorithm

First-Line Treatment Selection

Oral corticosteroids are the safest option for most elderly patients:

• Prednisone 30-40 mg daily for 5-7 days with rapid taper 1
• Preferred when patients have contraindications to colchicine or NSAIDs 3, 2
• Short-term use poses minimal risk even in patients with diabetes or hypertension 3
• Monitor blood glucose closely in diabetic patients during treatment

Intra-articular corticosteroid injection is the treatment of choice when a single accessible joint is involved 2

Second-Line: Low-Dose Colchicine

If corticosteroids are contraindicated:

• Initial dose: 1.2 mg followed by 0.6 mg after 1 hour 1
• NOT the traditional high-dose regimen - this causes excessive gastrointestinal toxicity
• Critical dose adjustments in renal impairment:
  • CrCl 30-60 mL/min: reduce dose by 50%
  • CrCl <30 mL/min: avoid or use single doses only 3
• Major drug interaction concerns: statins, clarithromycin, diltiazem, verapamil - risk of colchicine toxicity 3, 2

Avoid NSAIDs in Elderly Patients

NSAIDs are not recommended due to:

• High prevalence of renal impairment (often unrecognized)
• Cardiovascular disease risk
• Gastrointestinal bleeding risk
• Heart failure exacerbation 3, 2

Long-Term Urate-Lowering Therapy (ULT)

When to Initiate ULT

Start ULT in elderly patients with:

• Recurrent gout flares (≥2 per year)
• Tophi present
• Chronic kidney disease stage ≥3 4
• Can initiate during an acute flare - do not delay if decision is made 4

ULT Selection and Dosing

Allopurinol is the strongly recommended first-line agent for all patients, including those with moderate-to-severe CKD 4:

Start low and titrate slowly:

• Initial dose: 50-100 mg daily (even lower in CKD stage ≥3)
• Target serum urate: <6 mg/dL (<360 μmol/L)
• Titrate by 50-100 mg every 2-4 weeks as tolerated
• Maximum FDA-approved dose: 800 mg/day 4
• Do not restrict dose based solely on renal function - the traditional "CrCl-based dosing" often results in failure to achieve target urate levels 3, 5

Febuxostat as alternative:

• Does not require dose adjustment in mild-to-moderate renal disease 3, 5
• Start at 40 mg daily, can increase to 80 mg 4
• More expensive than allopurinol
• Consider in patients who fail allopurinol or have contraindications
• Particularly useful in diabetic patients with renal impairment - febuxostat 80 mg achieved target urate levels more effectively than allopurinol at standard doses 6

Mandatory Flare Prophylaxis During ULT Initiation

Strongly recommended: Continue prophylaxis for 3-6 months minimum 4:

• Low-dose colchicine 0.6 mg daily (if renal function permits)
• Prednisone 5-10 mg daily (if colchicine contraindicated)
• Continue longer if flares persist beyond 6 months

Special Considerations in Elderly Patients

Diabetes and Gout

• Gout affects 20% of patients with diabetes 7
• SGLT-2 inhibitors lower serum urate levels and may reduce gout risk - consider as glucose-lowering agent if patient has both conditions 8, 9
• Corticosteroids require close glucose monitoring but remain safe for short-term use 3
• Febuxostat and allopurinol are equally safe in diabetic patients 6

Renal Impairment

• Do not withhold ULT due to renal impairment - these patients benefit most 4, 10
• Allopurinol remains first-line even in CKD stage ≥3, but start at lower doses 4
• Probenecid is ineffective when CrCl <60 mL/min - avoid 4, 5

Medication Review

Discontinue or modify when possible:

• Thiazide and loop diuretics (major contributors to hyperuricemia) 2
• Beta-blockers if alternative antihypertensives available 2
• Continue low-dose aspirin if indicated for cardiovascular protection 2

Common Pitfalls to Avoid

• Do not use high-dose colchicine regimens - outdated and toxic 1
• Do not cap allopurinol at 300 mg without titrating to target urate - most patients require higher doses 4
• Do not avoid ULT in patients with CKD - they have highest disease burden 4, 10
• Do not start ULT without concomitant prophylaxis - will precipitate severe flares 4
• Do not use NSAIDs as first-line in elderly - too many contraindications 3, 2